Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity. - Wikidata - wikimedia - TriplyDB

Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity.

Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity.

http://www.wikidata.org/entity/Q37217297

about

Greater hunger and less restraint predict weight loss success with phentermine treatment.Can we win the war on obesity with pharmacotherapy?Comments on statistical issues in november 2013.

P2860

Q36395927-F83E301F-CC30-48E9-9FD3-08E6E426E359 Q38945034-3D9B72C7-B70E-4BF5-8663-08282CCD66F8 Q42835547-08AD30DF-7351-4B60-B195-BA784187681B

P2860

Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity.

http://www.wikidata.org/entity/Q37217297

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Postmarketing surveillance stu ...... mine in patients with obesity.

@en

Postmarketing surveillance stu ...... mine in patients with obesity.

@nl

type

label

Postmarketing surveillance stu ...... mine in patients with obesity.

@en

Postmarketing surveillance stu ...... mine in patients with obesity.

@nl

prefLabel

Postmarketing surveillance stu ...... mine in patients with obesity.

@en

Postmarketing surveillance stu ...... mine in patients with obesity.

@nl

P1433

Q37217297-BD943B4F-41BC-403F-9A05-DD10EB84ADED

P1476

Q37217297-B0E31A65-0607-4B53-A0EB-3F43ECD8DB57

P2093

Q37217297-24894E64-6FB9-4B07-AF39-A87C49D470FD

Q37217297-3F68B928-2372-4855-8964-4EEABF06C79B

Q37217297-497FF393-DA1B-4994-8CCA-09E7D4481DAD

Q37217297-8CAA130C-EC22-4F6C-9FC0-1AA5F285A982

Q37217297-961CA0BA-ECE1-49F4-A3D9-B2A4E3AA744A

Q37217297-97921C3D-D014-4FE3-9D38-4E11266F7EF6

Q37217297-9B6918B2-11D1-42A9-8DDA-C0915471E4A4

Q37217297-9F8A9CCE-8CFD-42C2-82C0-B89CB2689416

Q37217297-B55BCAEF-5F9B-4DEC-AEC5-3A8F95B147E4

Q37217297-CA0F69B5-50DF-4B20-BD84-F25A4773A860

P2860

Q37217297-25BB0046-A37A-4920-BB0D-B28D95401968

Q37217297-31FB3E2C-8BB0-4A61-9CEE-170AE72AE77A

Q37217297-7B44196B-FB6A-41D8-A010-52025B213319

Q37217297-8399AEC4-9E49-48CD-B814-2B2B6F2D352C

Q37217297-83ADD893-5E39-4B61-B4D3-65BF69E03E5E

Q37217297-9FC579C4-BCC9-437D-B1E2-9B0D38CFB47E

Q37217297-CA2BC9BB-0D63-41C6-9F32-1822CB280D61

Q37217297-E6187BF1-332F-4DD6-8F1E-A027765B8081

Q37217297-F15BEF4A-14B6-4776-A8DF-429EAF9AF3D4

Q37217297-F7AC66D7-0711-443A-B2F4-B537D5830DF5

P304

Q37217297-56839AF6-C18B-421A-BB07-A6275E322FB6

P31

Q37217297-D084F59C-34E7-4447-A06D-C22C44CE80F1

P356

Q37217297-E31ED7AA-AFDC-414D-94A2-E770DDA9D3EB

P433

Q37217297-58954C3D-7580-41C1-B717-40EA964C1CA7

P478

Q37217297-D724941F-83B8-448C-A3BB-3E916779F0A7

P577

Q37217297-14FD0B93-DCA8-4048-8988-43D208312FFB

P5875

Q37217297-1B8F05B3-CB75-437E-8973-A61428D4151E

P698

Q37217297-98BB067B-BAD9-45B0-8161-7FC1EAF718D3

P921

Q37217297-C01B03D7-DCEB-4E45-9BD2-1A95390E0FE0

P932

Q37217297-47339208-531A-42A2-9451-58EFFD5C5BA7

P356

KJFM.2013.34.5.298

P1433

Korean Journal of Family Medicine

P1476

Postmarketing surveillance stu ...... mine in patients with obesity.

@en

P2093

Bum Soo Kim

http://www.w3.org/2001/XMLSchema#string

Eun Sook Ahn

http://www.w3.org/2001/XMLSchema#string

Hee Won Suh

http://www.w3.org/2001/XMLSchema#string

Hyun Ok Kim

http://www.w3.org/2001/XMLSchema#string

In Soon Ahn

http://www.w3.org/2001/XMLSchema#string

Jin Mok Kim

http://www.w3.org/2001/XMLSchema#string

Jung Ah Lee

http://www.w3.org/2001/XMLSchema#string

Moon Kuk Kang

http://www.w3.org/2001/XMLSchema#string

Seong Gil Jung

http://www.w3.org/2001/XMLSchema#string

Young Gyu Park

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacotherapies for obesity: past, current, and future therapies

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies

Appetite-suppressing drugs and valvular heart disease.

Dietary pulmonary hypertension.

Pharmacological therapies for obesity.

Safety of drug therapies used for weight loss and treatment of obesity.

Pharmacological management of appetite expression in obesity.

Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients.

Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.

P304

298-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4082/KJFM.2013.34.5.298

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257536114

http://www.w3.org/2001/XMLSchema#string

P698

24106582

http://www.w3.org/2001/XMLSchema#string

P921

P932

3791337

http://www.w3.org/2001/XMLSchema#string